Detalles de la búsqueda
1.
Early systemic inflammation induces neurodevelopmental disorders: results from ARTEMIS, a French multicenter study of juvenile rheumatisms and systemic autoimmune and auto-inflammatory disorders and meta-analysis.
Mol Psychiatry
; 28(4): 1516-1526, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36747095
2.
Increased Incidence of Pediatric Uveitis Associated with the COVID-19 Pandemic Occurring Before COVID-19 Vaccine Implementation: A Time-Series Analysis.
J Pediatr
; 263: 113682, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37611738
3.
Association of atypical skin manifestations at the onset of systemic juvenile idiopathic arthritis with difficult-to-treat disease: A retrospective multicenter study.
J Am Acad Dermatol
; 87(6): 1425-1428, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35963289
4.
Clinical course of COVID-19 in a cohort of 342 familial Mediterranean fever patients with a long-term treatment by colchicine in a French endemic area.
Ann Rheum Dis
; 80(4): 539-540, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33139307
5.
[Familial mediterranean fever]. / Fièvre méditerranéenne familiale.
Rev Prat
; 73(8): 843-849, 2023 Oct.
Artículo
en Francés
| MEDLINE | ID: mdl-38354004
6.
Development of a score for early identification of children with Kawasaki disease requiring second-line treatment in multi-ethnic populations in Europe: A multicentre retrospective cohort study.
Lancet Reg Health Eur
; 22: 100481, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35982834
7.
Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.
Front Immunol
; 12: 744780, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858402
8.
The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.
Front Immunol
; 11: 971, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32670263
Resultados
1 -
8
de 8
1
Próxima >
>>